Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Ipca Laboratories Ltd Financial Statements & Historical Data

Updated NSE: IPCALABBSE: 524494
Report details
Last Updated:
Author: |Social: XLinkedIn

Ipca Laboratories Ltd: Earnings grew faster than sales in the quarter ending Jun 2026. Sales rose 20.7% to ₹2,788 crore against Jun 2025. Net profit rose 82.0% to ₹424 crore against the same period a year earlier. Operating margin rose from 18.0% to 24.0% (6.0 percentage points higher). For the full year ending Mar 2026, operating margin improved to 20.7%.

Calculated from the stored statements below · Reporting periods remain separate
COMPANY FINANCIAL DATA

Market snapshot

Stored figures, not live quotes. Price record: 9 October 2026, 8:51 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price1,915₹ per share
Reported P/E35.6Times
Book value per share318₹ per share
Reported ROCE17.0 %Reported return

Stored market and accounting figures

Price record: 9 October 2026, 8:51 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap48,830 Cr.
Current Price1,915
High / Low2,039/1,252
Stock P/E35.6
Book Value318
Dividend Yield0.31 %
ROCE17.0 %
ROE15.7 %
Face Value1.00

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

DAILY STORED OBSERVATIONS

Share price history

₹ per share

Last stored price for each available date, not a live quote or an official closing-price series. Missing dates are not filled. Verify corporate-action adjustments against the source.

Chart loads as you scroll.

EARNINGS

Quarterly performance

Jun 2026

Earnings grew faster than sales in the quarter ending Jun 2026. Sales rose 20.7% to ₹2,788 crore against Jun 2025. Net profit rose 82.0% to ₹424 crore against the same period a year earlier. Operating margin rose from 18.0% to 24.0% (6.0 percentage points higher). More operating profit was retained from each rupee of sales; check whether that improvement holds across other reporting periods.

Sales, expenses & profits

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
Quarterly statementAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 1,5852,0342,0532,0332,0932,3552,2452,2472,3092,5562,3922,3882,788
Expenses 1,2781,6731,7221,7111,7001,9131,7821,8181,8922,0121,8591,9052,119
Operating Profit 308361331322393441463429416545533484670
OPM % 19%18%16%16%19%19%21%19%18%21%22%20%24%
Other Income 45-191-118212620-17933-30384825
Interest 31443329242317221920182012
Depreciation 6990100989910098100100103108107111
Profit before tax 25222528977290345368128331392446404572
Tax % 34%39%23%96%31%29%25%49%29%28%18%24%26%
Net Profit 164136221119924627664233281364307424
EPS in Rs 6.425.727.092.357.589.059.782.679.1911.1412.8611.7915.84

Last Updated: September 29, 2026, 7:46 pm

EARNINGS

Annual performance

Mar 2026

Earnings grew faster than sales in the year ending Mar 2026. Sales rose 7.9% to ₹9,599 crore against Mar 2025. Net profit rose 50.8% to ₹1,184 crore against the same period a year earlier. Operating margin rose from 19.5% to 20.7% (1.3 percentage points higher). More operating profit was retained from each rupee of sales; check whether that improvement holds across other reporting periods.

Sales, expenses & profits

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
PER-SHARE EARNINGS

Earnings per share

Reported annual earnings per share use ₹ per share, while the earnings charts use ₹ crore. Changes in share count and corporate actions can affect the comparison between years.

Earnings per share

₹ per share

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
Annual statementAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: October 12, 2026, 3:15 am

MetricMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 3,1442,8673,1563,2583,7464,6195,3955,7976,2047,6628,8979,59910,126
Expenses 2,6042,5732,7052,8033,0513,7153,8434,4725,2726,3387,1667,6097,894
Operating Profit 5412944514556959041,5521,3259321,3241,7311,9902,232
OPM % 17%10%14%14%19%20%29%23%15%17%19%21%22%
Other Income 322111415665595412317-1148081
Interest 323527282220121148141887969
Depreciation 180163173178182210209232262357398418429
Profit before tax 3611172622915467391,3891,1367458431,1311,5731,814
Tax % 28%18%26%18%19%18%17%20%34%37%30%24%
Net Profit 254931952394426041,1418904795237851,1841,375
EPS in Rs 10.073.697.719.4917.6023.9944.9434.8518.5821.5729.0844.9851.63
Dividend Payout % 5%0%6%5%9%10%9%11%22%19%14%0%
Year-on-year profit growth table

YoY Net Profit Growth

Year2015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)-63.39%109.68%22.56%84.94%36.65%88.91%-22.00%-46.18%9.19%50.10%50.83%
Change in YoY Net Profit Growth (%)0.00%173.06%-87.11%62.37%-48.29%52.26%-110.91%-24.18%55.37%40.91%0.73%

Growth

Compounded Sales Growth
10 Years:11%
5 Years:14%
3 Years:15%
TTM:11%
Compounded Profit Growth
10 Years:13%
5 Years:7%
3 Years:-1%
TTM:44%
Stock Price CAGR
10 Years:14%
5 Years:6%
3 Years:15%
1 Year:-7%
Return on Equity
10 Years:13%
5 Years:14%
3 Years:10%
Last Year:13%

Last Updated: September 5, 2025, 7:50 am

CASH & FUNDING

Balance sheet

Mar 2026

Reported borrowings stood at ₹809 crore in Mar 2026. They decreased from ₹1,363 crore in Mar 2025 (40.6% lower). Read the borrowing notes, repayment schedule and cash-flow statement together; the borrowing balance alone does not establish liquidity or repayment capacity.

Reserves & borrowings

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
Balance-sheet statementAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: September 10, 2026, 1:30 am

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 252525252525252525252525
Reserves 2,1832,2342,4302,6633,0973,6024,6765,4675,8176,3076,9238,038
Borrowings 9358677166284655012658071,4811,4381,363809
Other Liabilities 6697657887999611,1301,0991,3381,3003,3263,4323,477
Total Liabilities 3,8123,8923,9604,1164,5495,2586,0667,6378,62311,09711,74412,350
Fixed Assets 1,8002,0141,9831,9531,9402,0592,0722,4182,7514,5544,2674,627
CWIP 267129957366133235306140343622773
Investments 162613687120310505989626862980844
Other Assets 1,7291,7231,7462,0032,4222,7563,2543,9245,1055,3395,8756,106
Total Assets 3,8123,8923,9604,1164,5495,2586,0667,6378,62311,09711,74412,350
CASH & FUNDING

Cash generation

Mar 2026

Operating activities generated ₹1,142 crore in Mar 2026. Reported free cash flow for the same period was ₹486 crore. Positive operating cash flow shows cash generated by operations in this period; examine its consistency and the capital expenditure needed to sustain the business. Operating cash flow was equivalent to 96.5% of the ₹1,184 crore reported annual profit for the same year ending Mar 2026, before capital expenditure.

Operating & free cash flow

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
Cash-flow statementAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 4687092823415015701,0908568069451,3211,142
Cash from Investing Activity + -689-218-149-135-165-509-521-851-725-1,215-870-247
Cash from Financing Activity + 251-462-159-130-183-137-306427507-553-283-754
Net Cash Flow 2929-2675153-76264432588-823169142
Free Cash Flow -207463147206322277731380347543551486
CFO/OP 100%251%74%88%88%80%86%80%110%94%97%78%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow-207.00463.00147.00206.00322.00277.00731.00380.00347.00543.00551.00486.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

OPERATING CYCLE

Capital efficiency

Mar 2025

Financial efficiency feed. Source: www.screener.in. The source URL identifies consolidated accounts. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

Working-capital days were 101 in Mar 2025. That is 10 days lower than the same annual period a year earlier. Compare collection, inventory and payment cycles within this feed to understand the movement; these measures do not identify the cause by themselves.

Working capital

Days

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
CAPITAL RETURNS

Returns on capital & equity

Financial efficiency feed. Source: www.screener.in. The source URL identifies consolidated accounts. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

Returns on capital & equity

%

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
Efficiency tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 504157586766715557588077
Inventory Days 272293289290286316294337337276350336
Days Payable 1109714513013715413514010183110111
Cash Conversion Cycle 213237200218216228229251293251321302
Working Capital Days 8268617480888810310271111101
ROCE %28%14%5%9%10%16%19%31%20%11%13%15%
SHAREHOLDERS

Ownership trends

Jun 2026

Promoters held 44.72% in Jun 2026. Their share was unchanged from Jun 2025. Ownership percentages can change through share issuance as well as transactions. Check exchange disclosures for the explanation and any pledging; the percentage alone is not evidence of investor conviction. DIIs held 37.04% in Jun 2026, 1.16 percentage points above their holding in Jun 2025. FIIs held 10.72% in Jun 2026, 0.05 percentage points above their holding in Jun 2025.

Shareholding comparison

%

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
SHAREHOLDER PARTICIPATION

Shareholder count

Shareholder count

Shareholders

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
Ownership tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters 46.29%46.29%46.30%46.30%46.30%44.72%44.72%44.72%44.72%44.72%44.72%44.72%
FIIs 9.86%10.27%10.51%10.85%10.83%11.06%10.75%10.67%10.42%10.62%10.63%10.72%
DIIs 34.72%34.19%34.05%33.46%33.90%35.36%35.73%35.88%36.45%36.99%37.13%37.04%
Government 0.32%0.32%0.32%0.32%0.32%0.32%0.32%0.32%0.32%0.32%0.32%0.32%
Public 8.80%8.93%8.82%9.07%8.64%8.53%8.45%8.41%8.09%7.33%7.21%7.19%
No. of Shareholders 95,93082,80981,16584,75382,97590,18988,30685,58282,87077,67382,18482,060
Mutual fund holdingsReported fund ownership · Expand table

Mutual Fund Holdings Data Table

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
HDFC Mid Cap Fund 17,994,512 2.87 2646.6317,920,3692026-02-23 07:11:400.41%
Kotak Midcap Fund 12,005,038 2.99 1765.7N/AN/AN/A
DSP Mid Cap Fund 4,290,936 3.31 631.114,637,7282026-02-23 08:52:00-7.48%
Nippon India Growth Mid Cap Fund 3,100,000 1.09 455.95N/AN/AN/A
Axis Midcap Fund 2,635,419 1.25 387.621,810,2342026-02-23 08:52:0045.58%
Kotak Large & Midcap Fund 2,510,000 1.23 369.17N/AN/AN/A
HDFC Balanced Advantage Fund 2,497,123 0.34 367.28N/AN/AN/A
DSP Small Cap Fund 2,101,047 1.92 309.022,320,0002026-02-23 08:52:00-9.44%
DSP Large & Mid Cap Fund 1,949,082 1.64 286.671,950,1962026-02-23 08:52:00-0.06%
DSP ELSS Tax Saver Fund 1,856,293 1.59 273.021,857,3992026-02-23 08:52:00-0.06%
ALTERNATE FEED

Financial ratios

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

Each card groups related ratios with the same unit. Reporting dates remain visible for every measure; the original ratio table follows the charts.

ALTERNATE RATIO FEED

Profitability ratios

%

Profitability ratios

%

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
ALTERNATE RATIO FEED

Liquidity ratios

Multiple (×)

Liquidity ratios

Multiple (×)

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
ALTERNATE RATIO FEED

Distributions & retention

%

Distributions & retention

%

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
ALTERNATE RATIO FEED

Interest coverage

Multiple (×)

Interest coverage

Multiple (×)

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
ALTERNATE RATIO FEED

Valuation multiples

Multiple (×)

Valuation multiples

Multiple (×)

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting ratio tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 1.001.001.001.002.00
Basic EPS (Rs.) 35.1425.8218.5834.8545.01
Diluted EPS (Rs.) 29.0821.5718.5834.8545.01
Cash EPS (Rs.) 46.7234.9429.7045.07107.06
Book Value[Excl.RevalReserv]/Share (Rs.) 273.88304.57233.16219.51371.79
Book Value[Incl.RevalReserv]/Share (Rs.) 273.88304.57233.16219.51371.79
Revenue From Operations / Share (Rs.) 352.37303.71246.13229.79427.28
PBDIT / Share (Rs.) 71.7056.9941.4854.23126.70
PBIT / Share (Rs.) 56.0242.9131.1745.07110.21
PBT / Share (Rs.) 44.5933.2229.3844.77109.50
Net Profit / Share (Rs.) 31.0420.8619.3935.9190.57
NP After MI And SOA / Share (Rs.) 29.0821.5718.5834.8589.87
PBDIT Margin (%) 20.3418.7616.8523.5929.65
PBIT Margin (%) 15.8914.1212.6619.6125.79
PBT Margin (%) 12.6510.9311.9319.4825.62
Net Profit Margin (%) 8.806.867.8715.6221.19
NP After MI And SOA Margin (%) 8.257.107.5415.1621.03
Return on Networth / Equity (%) 10.618.648.0616.0924.24
Return on Capital Employeed (%) 15.1512.4411.5918.5228.48
Return On Assets (%) 6.274.935.4611.5718.78
Long Term Debt / Equity (X) 0.070.090.110.070.00
Total Debt / Equity (X) 0.180.210.240.140.05
Asset Turnover Ratio (%) 0.780.780.760.790.91
Current Ratio (X) 2.632.352.873.042.96
Quick Ratio (X) 1.551.301.911.771.59
Inventory Turnover Ratio (X) 3.551.050.940.951.10
Dividend Payout Ratio (NP) (%) 13.759.2721.5311.478.90
Dividend Payout Ratio (CP) (%) 8.935.6013.849.087.52
Earning Retention Ratio (%) 86.2590.7378.4788.5391.10
Cash Earning Retention Ratio (%) 91.0794.4086.1690.9292.48
Interest Coverage Ratio (X) 21.4210.4623.11178.91177.79
Interest Coverage Ratio (Post Tax) (X) 12.695.6111.80119.46128.08
Enterprise Value (Cr.) 40485.2733899.8720234.9027148.8824038.82
EV / Net Operating Revenue (X) 4.534.403.244.664.44
EV / EBITDA (X) 22.2623.4519.2319.7314.96
MarketCap / Net Operating Revenue (X) 4.264.083.294.624.45
Retention Ratios (%) 86.2490.7278.4688.5291.09
Price / BV (X) 5.484.963.524.905.13
Price / Net Operating Revenue (X) 4.264.083.294.624.45
EarningsYield 0.010.010.020.030.04

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Ipca Laboratories Ltd 48,830 Cr. 1,915 2,039/1,25235.6 3180.31 %17.0 %15.7 % 1.00
Gland Pharma Ltd 50,674 Cr. 3,062 3,171/1,57435.9 6560.65 %17.4 %12.8 % 1.00
Glaxosmithkline Pharmaceuticals Ltd 43,030 Cr. 2,540 3,121/2,08840.9 1342.24 %61.4 %45.6 % 10.0
Ajanta Pharma Ltd 42,592 Cr. 3,410 3,797/2,38037.5 3620.94 %34.5 %27.1 % 2.00
Abbott India Ltd 55,143 Cr. 26,000 30,655/25,13534.2 2,2472.02 %44.8 %34.4 % 10.0
Industry Average17,127.26 Cr1,216.6253.25211.240.40%26.16%16.59%6.06

All Competitor Stocks of Ipca Laboratories Ltd

Explore Industry-wise Company financial data